economybharat.com

We Can Cover You
Click here
Facebook Youtube Instagram Linkedin
13
13

Approval

ACCOUNTOR FINAGO OY HAS RECEIVED THE NECESSARY REGULATORY APPROVAL FOR ITS VOLUNTARY RECOMMENDED PUBLIC CASH TENDER OFFER FOR ALL THE SHARES AND OPTION RIGHTS IN HEEROS PLC

ACCOUNTOR FINAGO OY HAS RECEIVED THE NECESSARY REGULATORY APPROVAL FOR ITS VOLUNTARY RECOMMENDED PUBLIC CASH TENDER OFFER FOR ALL THE SHARES AND OPTION RIGHTS IN HEEROS PLC

creativebharatgroup@gmail.com January 17, 2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY...
Read More Read more about ACCOUNTOR FINAGO OY HAS RECEIVED THE NECESSARY REGULATORY APPROVAL FOR ITS VOLUNTARY RECOMMENDED PUBLIC CASH TENDER OFFER FOR ALL THE SHARES AND OPTION RIGHTS IN HEEROS PLC
Eevia Health Plc receives approval for its top bilberry extract from an old customer and the first new order in 18 months of c. 572 KSEK (50 KEUR)

Eevia Health Plc receives approval for its top bilberry extract from an old customer and the first new order in 18 months of c. 572 KSEK (50 KEUR)

creativebharatgroup@gmail.com January 10, 2025
Eevia Health Plc (“Eevia” or “The Company”) has received approval of a second...
Read More Read more about Eevia Health Plc receives approval for its top bilberry extract from an old customer and the first new order in 18 months of c. 572 KSEK (50 KEUR)
Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia OG_NewsReleaseCompanyLogo_93006.jpg

Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia

creativebharatgroup@gmail.com December 27, 2024
Osaka, Japan & Cambridge, Mass., United States:   HYQVIA [Immune Globulin Infusion...
Read More Read more about Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia
Sealmatic Receives “In-Principle Approval” for Issue of 3,93,000 Equity Shares at Rs 637.10 per Equity Share from BSE OG_Companylog_92922.jpg

Sealmatic Receives “In-Principle Approval” for Issue of 3,93,000 Equity Shares at Rs 637.10 per Equity Share from BSE

creativebharatgroup@gmail.com December 18, 2024
Mumbai, Maharashtra, India:  Sealmatic India Ltd., listed on the Bombay Stock Exchange (BSE:...
Read More Read more about Sealmatic Receives “In-Principle Approval” for Issue of 3,93,000 Equity Shares at Rs 637.10 per Equity Share from BSE